Advanced science education in the regulatory arena: The Center for Drug Evaluation and research experience at the Food and Drug Administration

被引:0
|
作者
Ajayi, FO [1 ]
Wilcox, DF [1 ]
Uhl, K [1 ]
Quinn, J [1 ]
机构
[1] US FDA, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2002年 / 42卷 / 07期
关键词
D O I
10.1177/009127002401102650
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A challenge faced by the Center for Drug Evaluation and Research (CDER) in effectively carrying out its mission requires it to integrate the disciplines of science, medicine, law, and public policy. One way to do that is by ensuring a highly trained multidisciplinary staff, The CDER has been able to meet this requirement by identifying the core competencies needed to accomplish its mission. The use of a competency-based training model in the planning, development, and delivery of its advanced scientific education program allows CDER staff to maintain current knowledge as well as prepare for future scientific education needs, The CDER educational model could be readily adopted to meet the educational needs of other organizations. (C) 2002 the American College of Clinical Pharmacology.
引用
收藏
页码:711 / 717
页数:7
相关论文
共 50 条
  • [41] Regulatory Research to Support Food-Contact Infant Safety Assessment at US Food and Drug Administration
    Neal-Kluever, A. P.
    Aungst, J.
    Wu, Y.
    Liu, J.
    Shackelford, M.
    Ogungbesan, A.
    Gu, Y.
    Jacobs, K.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2016, 106 (05) : 404 - 404
  • [42] Current Drug Regulatory Status of Advanced Drug Evaluation System in Korea
    Park, In-Sook
    Kim, Deng Sup
    DRUG INFORMATION JOURNAL, 2009, 43 (01): : 41 - 46
  • [43] The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy: An Update
    Elahi, Merina
    Eshera, Noha
    Bambata, Nkosazana
    Barr, Helen
    Lyn-Cook, Beverly
    Beitz, Julie
    Rios, Maria
    Taylor, Deborah R.
    Lightfoote, Marilyn
    Hanafi, Nada
    DeJager, Lowri
    Wiesenfeld, Paddy
    Scott, Pamela E.
    Fadiran, Emmanuel O.
    Henderson, Marsha B.
    JOURNAL OF WOMENS HEALTH, 2016, 25 (03) : 222 - 234
  • [44] Current Drug Regulatory Status of Advanced Drug Evaluation System in Korea
    Pork I.-S.
    Kim D.S.
    Drug information journal : DIJ / Drug Information Association, 2009, 43 (1): : 41 - 46
  • [45] Innovation at the Food and Drug Administration's Device Center
    Maisel, William H.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (07) : 797 - 798
  • [46] Navigating the US Food and Drug Administration's Regulatory Science Initiative: An Imperative for Stem Cell Research and Regenerative Medicine Advocates
    Jakimo, Alan L.
    STEM CELLS AND DEVELOPMENT, 2013, 22 : 73 - 78
  • [47] Opportunities for Consumer Research from the Food and Drug Administration's Center for Tobacco Products
    Andrews, J. Craig
    Choiniere, Conrad J.
    Portnoy, David B.
    JOURNAL OF PUBLIC POLICY & MARKETING, 2015, 34 (01) : 119 - 130
  • [48] Phototoxicology and photocarcinogenesis at the US Food and Drug Administration's National Center for Toxicological Research
    Howard, PC
    Sams, RL
    Bucher, JR
    Allaben, WT
    JOURNAL OF FOOD AND DRUG ANALYSIS, 2002, 10 (04) : 252 - 257
  • [49] Food and Drug Administration Regulation and Evaluation of Vaccines
    Marshall, Valerie
    Baylor, Norman W.
    PEDIATRICS, 2011, 127 : S23 - S30
  • [50] Evaluation of drug-grapefruit interaction labeling at the food and drug administration
    Piazza-Hepp, T
    Huang, SM
    Hepp, P
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1062 - 1062